These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 14688506)

  • 1. Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study.
    Pedersen OD; Brendorp B; Køber L; Torp-Pedersen C
    Congest Heart Fail; 2003; 9(6):333-40. PubMed ID: 14688506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
    Torp-Pedersen C; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen J; Videbaek J; Marchant B; Camm AJ
    N Engl J Med; 1999 Sep; 341(12):857-65. PubMed ID: 10486417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
    Schmiegelow MD; Pedersen OD; Køber L; Seibæk M; Abildstrøm SZ; Torp-Pedersen C
    BMC Cardiovasc Disord; 2011 May; 11():19. PubMed ID: 21569543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    Frasure-Smith N; Lespérance F; Talajic M; Khairy P; Dorian P; O'Meara E; Roy D
    Circ Heart Fail; 2012 May; 5(3):322-30. PubMed ID: 22441774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation in heart failure: prognostic significance and management.
    Naccarelli GV; Hynes BJ; Wolbrette DL; Bhatta L; Khan M; Samii S; Luck JC
    J Cardiovasc Electrophysiol; 2003 Dec; 14(12 Suppl):S281-6. PubMed ID: 15005215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study.
    Pedersen OD; Brendorp B; Elming H; Pehrson S; Køber L; Torp-Pedersen C
    Card Electrophysiol Rev; 2003 Sep; 7(3):220-4. PubMed ID: 14739717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure.
    Torp-Pedersen C; Moller M; Kober L; Camm AJ
    Eur Heart J; 2000 Aug; 21(15):1204-6. PubMed ID: 10924306
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy.
    Pedersen OD; Bagger H; Keller N; Marchant B; Køber L; Torp-Pedersen C
    Circulation; 2001 Jul; 104(3):292-6. PubMed ID: 11457747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation and congestive heart failure.
    Roy D; Talajic M; Dubuc M; Thibault B; Guerra P; Macle L; Khairy P
    Curr Opin Cardiol; 2009 Jan; 24(1):29-34. PubMed ID: 19102036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qt dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function.
    Brendorp B; Elming H; Jun L; Køber L; Malik M; Jensen GB; Torp-Pedersen C
    Circulation; 2001 Feb; 103(6):831-5. PubMed ID: 11171791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dofetilide in patients with chronic heart failure and left ventricular dysfunction].
    Latini R
    Ital Heart J Suppl; 2000 Mar; 1(3):427-8. PubMed ID: 10815277
    [No Abstract]   [Full Text] [Related]  

  • 14. Dofetilide: a new class III antiarrhythmic agent.
    Roukoz H; Saliba W
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):9-19. PubMed ID: 17187453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation in the heart failure population.
    Offutt C
    J Cardiovasc Nurs; 2004; 19(6 Suppl):S3-10. PubMed ID: 15529071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation in heart failure.
    Stevenson WG; Stevenson LW
    N Engl J Med; 1999 Sep; 341(12):910-1. PubMed ID: 10486424
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study.
    Singh SN
    Card Electrophysiol Rev; 2003 Sep; 7(3):225-8. PubMed ID: 14739718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
    Savelieva I; John Camm A
    Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
    O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
    Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
    Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.